MMP inhibition in abdominal aortic aneurysms: Rationale for a prospective randomized clinical trial

Medicine & Life Sciences

• Abdominal Aortic Aneurysm 77%
• Matrix Metalloproteinases 67%
• Doxycycline 53%
• Randomized Controlled Trials 47%
• Aneurysm 27%
• Matrix Metalloproteinase 2 25%
• Matrix Metalloproteinase Inhibitors 18%
• Matrix Metalloproteinase 9 16%
• human MMP9 protein 13%
• Elastin 9%
• Southern Blotting 8%
• Tetracycline 8%
• Cell Wall 7%
• Connective Tissue 7%
• Reverse Transcription 6%
• Rupture 6%
• Collagen 5%
• Animal Models 5%
• Polymerase Chain Reaction 4%
• Blood Vessels 4%
• In Vitro Techniques 3%
• Therapeutics 2%

Chemical Compounds

• Doxycycline 100%
• Matrix Metalloproteinase Inhibitor 35%
• Twice Daily 18%
• Elastin 15%
• Tetracycline 13%
• Chain Reaction 11%
• Collagen 11%
• Reduction 10%
• Time 4%

Arts & Humanities

• Clinical Trials 83%
• Degradation 11%
• Fold 11%
• Polymerase Chain Reaction 11%
• Animal Model 7%
• Collagen 6%
• Connectives 5%
• Transcription 5%
• Repair 5%
• Rupture 5%
• Surgery 5%
• Derivatives 5%
• Cells 4%